243560 When corporations create diseases, womens' health suffers

Monday, October 31, 2011: 10:50 AM

Cynthia A. Pearson , National Women's Health Network, Washington, DC
Amy Allina , National Women's Health Network, Washington, DC
Suffering from osteopenia? Think you might have hypoactive desire disorder? How about imbalanced hormones? If you've been told you have any of these conditions, you've experienced the corporatization of disease. As public health advocates, we're responsible for educating the public, often about conditions or concerns previously unknown to them. As generalists, we often rely upon external sources of information for our own knowledge about new and emerging conditions. The author will demonstrate that external sources of information about new conditions, such as professional guidelines, review articles, and consensus statements, are often influenced by the corporations which will benefit from the newly defined disorder. The author will examine the development and promotion of osteopenia and female sexual disorders as examples of this practice and point out ways in which public health advocates can identify corporate influence.

Learning Areas:
Administer health education strategies, interventions and programs
Advocacy for health and health education
Assessment of individual and community needs for health education
Public health or related laws, regulations, standards, or guidelines

Learning Objectives:
1. Explain the steps typically taken by corporations to create acceptance of a new condition. 2. Name three conditions for which independent evidence of a disease has not yet been established.

Keywords: Women's Sexuality, Health Care Politics

Presenting author's disclosure statement:

Qualified on the content I am responsible for because: I am qualified to present because I oversee policy advocacy programs on various women's health topics.
Any relevant financial relationships? No

I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.